Replies to post #689806 on NorthWest Biotherapeutics Inc (NWBO)

[RobotDroid]

Ex is not worthy of a response, thats only the second time in years I have looked at his reply. Never again will I do that as I loathe suffering fools. I agree as they tinker with dvax and the combo's drugs, they may find all kinds of interesting applications. All solid tumors is a good start. No pr on nwbo website yet, it will be interesting to see what news organizations pick up the story. I did send the Nature link to Drudge.

[learningcurve2020]

>>In the GBM patient subset, TLR agonist treatment also significantly lowered risk of recurrence, but not risk of death (Fig. 3E, Supplementary Fig. 3B).